Skip to content
← Measures

prom

BASDAI · Bath Ankylosing Spondylitis Disease Activity Index

6 items · 3 min · 0–10 · lower is better

1 Before you use it

What it is

Six questions on the last week — fatigue, spinal pain, peripheral joint pain and swelling, areas of localised tenderness, and morning stiffness (severity and duration).

The standard disease-activity measure in axial spondyloarthritis, and the one that tells you whether the medical management is working.

When to reach for it

Any patient with known or suspected axial spondyloarthritis, at baseline and review.

Suspicion alone is a referral, not a BASDAI. Inflammatory back pain features — under 40 at onset, insidious, better with exercise and worse with rest, night pain, prolonged morning stiffness — belong in a rheumatology letter.

2 Giving it

Scoring

Six 0–10 items. The two morning-stiffness items are averaged into one, then the five resulting values are averaged to give 0–10.

That averaging step is where students get it wrong.

What it doesn’t measure

Function — that is BASFI. Spinal mobility — that is BASMI. And it does not diagnose. The three Bath measures are designed to be used together.

Repeat it

Each medical review, usually 8 to 12 weeks apart, alongside the BASFI. It tracks disease activity, not your last session.

3 Reading the score

Interpreting it

A score of 4 or above is conventionally used as the threshold for active disease and as one trigger for escalating medical therapy.

Morning stiffness duration is the item to watch clinically. UniSA coding: over 30 minutes is In — and in this population it is a disease-activity signal rather than a mechanical one.

Is the change real?

MCID 10 mm, or 22.5% relative change. Compare the change against this patient's own baseline as well as the figure. SourceMeasured in ankylosing spondylitis.

On placement

Ankylosing spondylitis, on a biologic and a loading programme. BASDAI 5.2 at intake, 4.0 at the 12-week review.

Read it as 1.2 points down on a 0–10 scale — 12 mm on the 100 mm items, and a 23% relative change. Both sides of the verified MCID (10 mm or 22.5%, measured in ankylosing spondylitis) are cleared, just. The 4.0 also sits on the conventional active-disease threshold, so this is a patient who moved but is not out of the woods.

Do report it to the rheumatology team with the morning-stiffness item pulled out — that item is the disease-activity signal — and keep the programme going.

Student trap. Averaging all six items straight. The two stiffness items are combined first — do it in the wrong order and every score you record is wrong.

Official source: basdai.com. We don't host the form.

This is a learning tool. It does not diagnose patients and does not replace your clinical educator.

Did this page do its job?

CliniStudy is in beta. One tap is enough — it decides what gets fixed first.